ClinicalTrials.Veeva

Menu

The Number of Blastocysts Formed in the Outcome of Freeze All Strategy: COMFFETI Trial, Cumulative Delivery Rate

A

Assisting Nature

Status

Unknown

Conditions

Pregnancy, Ovarian

Treatments

Diagnostic Test: Pregnancy Rate

Study type

Observational

Funder types

Other

Identifiers

NCT03463278
Blastocyst-AN004

Details and patient eligibility

About

A prospective study of the blastulation rate in the outcome of the Freeze all strategy

Full description

A prospective study of the blastulation rate in women under the age of 40 years following Freeze all strategy, according to AMH levels and sperm parameters.

Study group 1: number of vitrified blastocysts 0-4 Study group 2: number of vitrified blastocysts 5-7 Study group 3: number of vitrified blastocysts >7

Enrollment

160 estimated patients

Sex

Female

Ages

20 to 39 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • primary infertility
  • age 20-39 years;
  • body mass index (BMI) 18-29kg/m2;
  • regular menstrual cycle of 26-35days,
  • presumed to be ovulatory;
  • >1mil/ml spermatozoa;
  • short antagonist protocol

Exclusion criteria

  • poor responders;
  • age ≥40;
  • TESE sperm;
  • PGS cycles;
  • donor oocytes;
  • donor sperm

Trial design

160 participants in 3 patient groups

0-4 blastocysts
Description:
group A: cumulative pregnancy rate of 0-4 blastocysts vitrified
Treatment:
Diagnostic Test: Pregnancy Rate
5-7 blastocysts
Description:
group B: cumulative pregnancy rate of 5-7 blastocysts vitrified
Treatment:
Diagnostic Test: Pregnancy Rate
>7 blastocysts
Description:
group C: cumulative pregnancy rate of \>7 blastocysts vitrified
Treatment:
Diagnostic Test: Pregnancy Rate

Trial contacts and locations

1

Loading...

Central trial contact

Tatiana Chartomatsidou, MSc

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems